Breaking News Instant updates and real-time market news.

A

Agilent

$71.06

0.45 (0.64%)

, BIO

Bio-Rad

$252.23

0.56 (0.22%)

04:55
12/12/18
12/12
04:55
12/12/18
04:55

American Society of Cell Biology to hold a meeting

ASCB/EMBO 2018 Annual Meeting to be held in San Diego, CA on December 8-12.

A

Agilent

$71.06

0.45 (0.64%)

BIO

Bio-Rad

$252.23

0.56 (0.22%)

BRKR

Bruker

$31.34

0.11 (0.35%)

BTX

Ticker changed to LCTX

$1.28

-0.03 (-2.29%)

FTK

Flotek

$1.24

0.015 (1.23%)

TMO

Thermo Fisher

$237.50

0.42 (0.18%)

UPMKY

UPM-Kymmene

$0.00

(0.00%)

A Agilent
$71.06

0.45 (0.64%)

09/17/18
GSCO
09/17/18
DOWNGRADE
GSCO
Neutral
Thermo Fisher downgraded to Neutral from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Patrick Donnelly downgraded Thermo Fisher (TMO) to Neutral from Conviction Buy with an unchanged price target of $250. The analyst coupled the downgrade with an upgrade of Agilent Technologies (A) to Conviction Buy from Buy. The analyst believes his thesis on Thermo Fisher, centering around deal-driven accelerating growth and margin expansion, is more appropriately reflected in the current valuation. Further, the company faces a difficult set of comps starting in Q4 of this year, Donnelly tells investors in a research note. The analyst remains positive on Thermo Fisher's fundamentals, but prefers the set-up for Agilent at current valuation levels.
09/17/18
GSCO
09/17/18
UPGRADE
Target $82
GSCO
Conviction Buy
Agilent upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Patrick Donnelly added Agilent Technologies (A) to his firm's Conviction List and keeps a Buy rating on the shares. The analyst upped his price target for the stock to $82 from $77. Donnelly names Agilent his top pick in Life Science Tools ahead of Q3 earnings season. Agilent provides a "a rare Tools opportunity" to own an "accelerating growth story at a reasonable valuation," Donnelly tells investors in a research note. Further, the analyst sees "untapped capital allocation upside" that could potentially be unlocked by the new CFO.
11/12/18
CLVD
11/12/18
DOWNGRADE
CLVD
Neutral
Agilent downgraded to Neutral from Buy at Cleveland Research
11/20/18
JPMS
11/20/18
NO CHANGE
Target $80
JPMS
Overweight
Agilent reported 'exceedingly strong quarter,' says JPMorgan
JPMorgan analyst Tycho Peterson says Agilent Technologies reported an "exceedingly strong quarter," with core growth of 9% "well above guidance and elevated expectations." The analyst continues to like the story and maintain an Overweight rating on the shares with an $80 price target. Heading into fiscal 2019 and beyond, Peterson continues to see "multiple drivers" to accelerate growth, including the Intuvo/Ultivo product cycles and accelerating momentum in biopharma.
BIO Bio-Rad
$252.23

0.56 (0.22%)

09/20/18
MSCO
09/20/18
INITIATION
Target $335
MSCO
Equal Weight
Bio-Rad initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Steve Beuchaw initiated Bio-Rad with an Equal Weight rating and $335 price target, stating that its organic growth acceleration, margin expansion and $1.5B increase in the value of its 30% stake in German bioprocess/lab products and instruments maker Sartorius add up to a "great story," but a stock that is "not cheap." He expects EPS to track 5%-10% above consensus by 2020, but still struggles to find upside given the stock's current levels, Beuchaw tells investors.
09/24/18
JEFF
09/24/18
NO CHANGE
Target $420
JEFF
Buy
Jefferies boosts Bio-Rad target to $420, adds to Franchise Picks List
Jefferies analyst Brandon Couillard raised his price target for Bio-Rad Laboratories to $420 and added the shares to his firm's Franchise Picks List. The analyst sees "substantial hidden value" in Bio-Rad's droplet digital PCR franchise that he believes is underappreciated by investors. ddPCR is a disruptive technology that can grow at 20%-plus annually, capable of driving a sustained organic growth acceleration for the company thru 2021, Couillard tells investors in a research note. Further, he believes base Bio-Rad business trades at only 6.3 times estimated 2020 EBITDA, or a 60% discount to peers. The analyst keeps a Buy rating on the shares.
09/20/18
09/20/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Westport (WPRT) initiated with a Buy at H.C. Wainwright. 2. Legacy Reserves (LGCY) initiated with a Neutral at Seaport Global. 3. Tandem Diabetes (TNDM) initiated with a Buy at Craig-Hallum. 4. Bio-Rad (BIO) initiated with an Equal Weight at Morgan Stanley. 5. Brookfield (BAM) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/17/18
GSCO
10/17/18
INITIATION
Target $350
GSCO
Buy
Bio-Rad initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Patrick Donnelly started Bio-Rad Laboratories with a Buy rating and $350 price target. The analyst sees above-average earnings growth for the company and thinks its margin expansion story is in the early stages.
BRKR Bruker
$31.34

0.11 (0.35%)

09/20/18
09/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Seaspan (SSW) downgraded to Hold from Buy at Deutsche Bank with analyst Amit Mehrotra citing the recent strong performance of the shares and increased risk from the trade war between China and the U.S. 2. Bruker (BRKR) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Steve Beuchaw citing three company-specific leading indicators that he says point to a slower revenue outlook. 3. Stitch Fix (SFIX) downgraded to Neutral from Overweight at Piper Jaffray with analyst Erinn Murphy citing valuation. 4. Nutrien (NTR) downgraded to Outperform from Focus List at Scotiabank. 5. JD.com (JD) downgraded to Underperform from Outperform at CLSA with the firm lowering its price target to $29 and saying the second half will remain challenging. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/09/18
UBSW
10/09/18
INITIATION
Target $30
UBSW
Sell
Bruker initiated with a Sell at UBS
UBS analyst Daniel Brennan initiated Bruker with a Sell rating and $30 price target.
10/09/18
UBSW
10/09/18
NO CHANGE
UBSW
UBS initiates coverage of Life Sciences and Diagnostics Tools sector
UBS analyst Daniel Brennan initiated coverage of the Life Sciences and Diagnostics Tools sector. He said demand is accelerating across his universe but valuations are extended. He expects strong fundamentals to continue into 2019 but he said selectivity is the key. In the group, his Buy ratings include Exact Sciences (EXAS), Iqvia (IQV), NanoString (NSTG), Syneos Health (SYNH) and Thermo Fisher (TMO).
09/20/18
09/20/18
DOWNGRADE
Target $32

Underweight
Bruker downgraded to Underweight on end market worries at Morgan Stanley
As previously reported, Morgan Stanley analyst Steve Beuchaw downgraded Bruker to Underweight from Equal Weight, citing three company-specific leading indicators that he says point to a slower revenue outlook. He sees a deceleration in key markets in semiconductors and materials, which Beuchaw notes represent about 20% of Bruker's sales but only about 7% for the Tools industry; his survey work highlights moderating growth expectations in its key NMR segments; and comps over the next 12 months are tougher than they were over the last year. Beuchaw lowered his revenue estimates for Bruker by 2% and 6%, respectively, for 2019 and 2020 but raised his price target slightly to $32 from $31 to account for a higher group multiple.
BTX Ticker changed to LCTX
$1.28

-0.03 (-2.29%)

02/02/18
LSCM
02/02/18
INITIATION
Target $8
LSCM
Buy
BioTime initiated with a Buy at Lake Street
Lake Street analyst Bruce Jackson started BioTime with a Buy rating and $8 price target. The company may appear complex given its interdependent corporate structure, but there is reward for investors who can recognize the value creation underway at both BioTime and its minority investments, Jackson tells investors in a research note.
12/10/18
OPCO
12/10/18
INITIATION
Target $3.5
OPCO
Outperform
BioTime initiated with an Outperform at Oppenheimer
Oppenheimer analyst Kevin DeGeeter started BioTime with an Outperform rating and $3.50 price target. New management is transforming BioTime from a holding company of multiple technology platforms to a product development company "committed to allocating necessary resources to the most promising drug," OpRegen for the treatment of dry age-related macular degeneration, DeGeeter tells investors in a research note. He expects OpRegen to have peak end-market revenue of $1.3B.
FTK Flotek
$1.24

0.015 (1.23%)

08/08/18
GHSC
08/08/18
DOWNGRADE
GHSC
Neutral
Flotek downgraded to Neutral from Buy at Seaport Global
Seaport Global analyst Mike Urban downgraded Flotek to Neutral from Buy following the Q2 miss. Urban said "everything that could have gone wrong did" as the company missed "badly" on revenue and margins. The analyst does not see any positive catalysts in the short-to-intermediate term and said shares will likely be "dead money" at best until results improve.
TMO Thermo Fisher
$237.50

0.42 (0.18%)

10/18/18
10/18/18
DOWNGRADE

Neutral
Follow-up: Thermo Fisher downgraded to Neutral at Cleveland Research
As previously reported, Cleveland Research downgraded Thermo Fisher to Neutral from Buy. Analyst Steve Willoughby said feedback indicates "extremely strong trends" in the industry are "unlikely to be sustained" at the same rate going into 2019. The analyst is now assuming softer than expected organic growth, less contribution from M&A, and FX headwinds. Willoughby is now slightly below consensus with his estimates and sees less upside in shares going forward.
10/18/18
CLVD
10/18/18
DOWNGRADE
CLVD
Neutral
Thermo Fisher downgraded to Neutral from Buy at Cleveland Research
10/09/18
UBSW
10/09/18
INITIATION
Target $295
UBSW
Buy
Thermo Fisher initiated with a Buy at UBS
UBS analyst Daniel Brennan initiated Thermo Fisher with a Buy rating and $295 price target.
UPMKY UPM-Kymmene
$0.00

(0.00%)

TODAY'S FREE FLY STORIES

WSM

Williams-Sonoma

$70.48

-0.88 (-1.23%)

21:33
11/12/19
11/12
21:33
11/12/19
21:33
Initiation
Williams-Sonoma initiated  »

Williams-Sonoma initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$84.57

1.28 (1.54%)

21:31
11/12/19
11/12
21:31
11/12/19
21:31
Initiation
Wayfair initiated  »

Wayfair initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

VFC

VF Corp.

$84.69

-1.7 (-1.97%)

21:28
11/12/19
11/12
21:28
11/12/19
21:28
Initiation
VF Corp. initiated  »

VF Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$30.85

0.295 (0.97%)

21:25
11/12/19
11/12
21:25
11/12/19
21:25
Initiation
Urban Outfitters initiated  »

Urban Outfitters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

UAA

Under Armour

$17.29

-0.295 (-1.68%)

21:23
11/12/19
11/12
21:23
11/12/19
21:23
Initiation
Under Armour initiated  »

Under Armour initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$244.06

2.19 (0.91%)

21:19
11/12/19
11/12
21:19
11/12/19
21:19
Initiation
Ulta Beauty initiated  »

Ulta Beauty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

TJX

TJX

$58.40

-0.14 (-0.24%)

21:15
11/12/19
11/12
21:15
11/12/19
21:15
Initiation
TJX initiated  »

TJX initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TPR

Tapestry

$26.38

-0.295 (-1.11%)

21:12
11/12/19
11/12
21:12
11/12/19
21:12
Initiation
Tapestry initiated  »

Tapestry initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

AFL

Aflac

$53.97

-0.04 (-0.07%)

21:02
11/12/19
11/12
21:02
11/12/19
21:02
Hot Stocks
Aflac names Frederick Crawford new COO »

Aflac announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$110.97

-1.16 (-1.03%)

21:00
11/12/19
11/12
21:00
11/12/19
21:00
Initiation
Ross Stores initiated  »

Ross Stores initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

RL

Ralph Lauren

$111.44

-2.58 (-2.26%)

20:57
11/12/19
11/12
20:57
11/12/19
20:57
Initiation
Ralph Lauren initiated  »

Ralph Lauren initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$174.48

-0.18 (-0.10%)

20:56
11/12/19
11/12
20:56
11/12/19
20:56
Initiation
RH initiated  »

RH initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVH

PVH Corp.

$96.91

0.14 (0.14%)

20:53
11/12/19
11/12
20:53
11/12/19
20:53
Initiation
PVH Corp. initiated  »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

JWN

Nordstrom

$36.90

-0.52 (-1.39%)

20:51
11/12/19
11/12
20:51
11/12/19
20:51
Initiation
Nordstrom initiated  »

Nordstrom initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NKE

Nike

$89.51

-0.52 (-0.58%)

20:46
11/12/19
11/12
20:46
11/12/19
20:46
Initiation
Nike initiated  »

Nike initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EYE

National Vision

$27.03

0.24 (0.90%)

20:43
11/12/19
11/12
20:43
11/12/19
20:43
Initiation
National Vision initiated  »

National Vision initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$17.53

0.02 (0.11%)

20:40
11/12/19
11/12
20:40
11/12/19
20:40
Initiation
L Brands initiated  »

L Brands initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BABA

Alibaba

$186.97

0.26 (0.14%)

20:25
11/12/19
11/12
20:25
11/12/19
20:25
Periodicals
Alibaba gets approval to sell shares in Hong Kong, SCMP reports »

Alibaba has received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ENR

Energizer

$42.01

-1.1 (-2.55%)

, SPB

Spectrum Brands

$51.19

-0.76 (-1.46%)

20:25
11/12/19
11/12
20:25
11/12/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ENR

Energizer

$42.01

-1.1 (-2.55%)

SPB

Spectrum Brands

$51.19

-0.76 (-1.46%)

SSYS

Stratasys

$20.74

0.04 (0.19%)

FVRR

Fiverr

$21.56

-0.47 (-2.13%)

MTOR

Meritor

$23.44

-0.25 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 21

    Nov

  • 09

    Dec

  • 12

    Dec

DDOG

Datadog

$34.40

0.89 (2.66%)

20:02
11/12/19
11/12
20:02
11/12/19
20:02
Hot Stocks
Datadog establishes Japanese subsidiary »

Datadog announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 19

    Nov

NKE

Nike

$89.51

-0.52 (-0.58%)

, AMZN

Amazon.com

$1,778.33

6.63 (0.37%)

19:40
11/12/19
11/12
19:40
11/12/19
19:40
Periodicals
Nike says to end retail pilot project w/ Amazon.com but continue AWS partnership 

Report from Bloomberg.

NKE

Nike

$89.51

-0.52 (-0.58%)

AMZN

Amazon.com

$1,778.33

6.63 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

HPE

HP Enterprise

$17.34

-0.11 (-0.63%)

, FJTSY

Fujitsu

$0.00

(0.00%)

19:34
11/12/19
11/12
19:34
11/12/19
19:34
Hot Stocks
HP Enterprise's Cray to partner with Fujitsu on 'supercomputer' technology »

Cray, a Hewlett Packard…

HPE

HP Enterprise

$17.34

-0.11 (-0.63%)

FJTSY

Fujitsu

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

IMAX

Imax

$21.26

-0.62 (-2.83%)

19:23
11/12/19
11/12
19:23
11/12/19
19:23
Hot Stocks
Imax names Edwin Tan as CEO of Imax China »

IMAX China announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$308.96

0.57 (0.18%)

19:21
11/12/19
11/12
19:21
11/12/19
19:21
Periodicals
Tariffs on China imports become stumbling block to trade pact, WSJ says »

Tariffs are emerging as…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$308.96

0.57 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$0.67

-0.138 (-17.08%)

19:19
11/12/19
11/12
19:19
11/12/19
19:19
Hot Stocks
Chesapeake CEO says 'strongly' believes in current capital program »

November 12, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.